Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma

Journal:
Blood
Published:
DOI:
10.1182/blood.2024026534
Affiliations:
4
Authors:
9
Go to article
Institutions Authors Share
The Institute of Cancer Research (ICR), United Kingdom (UK)
4.833333
 0.54
Weill Cornell Medicine, United States of America (USA)
2.333333
 0.26
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
1.833333
 0.20
Interested in Cardiovascular Medicine and Haematology?